313 related articles for article (PubMed ID: 31256261)
1. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.
Frea S; Pidello S; Volpe A; Canavosio FG; Galluzzo A; Bovolo V; Camarda A; Golzio PG; D'Ascenzo F; Bergerone S; Rinaldi M; Gaita F
Clin Res Cardiol; 2020 Apr; 109(4):417-425. PubMed ID: 31256261
[TBL] [Abstract][Full Text] [Related]
2. Diuretic strategies in patients with acute decompensated heart failure.
Felker GM; Lee KL; Bull DA; Redfield MM; Stevenson LW; Goldsmith SR; LeWinter MM; Deswal A; Rouleau JL; Ofili EO; Anstrom KJ; Hernandez AF; McNulty SE; Velazquez EJ; Kfoury AG; Chen HH; Givertz MM; Semigran MJ; Bart BA; Mascette AM; Braunwald E; O'Connor CM;
N Engl J Med; 2011 Mar; 364(9):797-805. PubMed ID: 21366472
[TBL] [Abstract][Full Text] [Related]
3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
4. Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial.
Galluzzo A; Frea S; Boretto P; Pidello S; Volpe A; Canavosio FG; Golzio PG; Bergerone S; De Ferrari GM
Clin Res Cardiol; 2020 Oct; 109(10):1251-1259. PubMed ID: 32144493
[TBL] [Abstract][Full Text] [Related]
5. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R
ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452
[TBL] [Abstract][Full Text] [Related]
6. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
[TBL] [Abstract][Full Text] [Related]
7. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
[TBL] [Abstract][Full Text] [Related]
8. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
[TBL] [Abstract][Full Text] [Related]
9. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
[TBL] [Abstract][Full Text] [Related]
10. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
[TBL] [Abstract][Full Text] [Related]
11. Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.
Kuriyama A; Urushidani S
Heart Fail Rev; 2019 Jan; 24(1):31-39. PubMed ID: 30054781
[TBL] [Abstract][Full Text] [Related]
12. Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
Wu MY; Chang NC; Su CL; Hsu YH; Chen TW; Lin YF; Wu CH; Tam KW
J Crit Care; 2014 Feb; 29(1):2-9. PubMed ID: 24331943
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of continuous vs intermittent infusion of loop diuretics in hospitalized patients.
Alqahtani F; Koulouridis I; Susantitaphong P; Dahal K; Jaber BL
J Crit Care; 2014 Feb; 29(1):10-7. PubMed ID: 23683555
[TBL] [Abstract][Full Text] [Related]
14. Diuretic dosing in acute decompensated heart failure: lessons from DOSE.
Campbell PT; Ryan J
Curr Heart Fail Rep; 2012 Sep; 9(3):260-5. PubMed ID: 22699924
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
16. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P
J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
Ng KT; Yap JLL
Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
[TBL] [Abstract][Full Text] [Related]
18. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
[TBL] [Abstract][Full Text] [Related]
19. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
[TBL] [Abstract][Full Text] [Related]
20. Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis.
Chan JSK; Kot TKM; Ng M; Harky A
J Card Fail; 2020 Sep; 26(9):786-793. PubMed ID: 31730917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]